Healthcare - Biotechnology - NASDAQ - US
$ 170.74
-3.75 %
$ 4.91 B
Market Cap
96.46
P/E
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome.[ Read More ]
The intrinsic value of one KRYS stock under the base case scenario is HIDDEN Compared to the current market price of 171 USD, Krystal Biotech, Inc. is HIDDEN
2. FUNDAMENTAL
ANALYSIS
Price Chart KRYS
FINANCIALS
50.7 M
REVENUE
-110 M
OPERATING INCOME
10.9 M
NET INCOME
-88.8 M
OPERATING CASH FLOW
82.6 M
INVESTING CASH FLOW
203 M
FINANCING CASH FLOW
83.8 M
REVENUE
22.4 M
OPERATING INCOME
27.2 M
NET INCOME
58.9 M
OPERATING CASH FLOW
-34.3 M
INVESTING CASH FLOW
3.36 M
FINANCING CASH FLOW
Balance Sheet Decomposition
Krystal Biotech, Inc.
| Current Assets | 588 M |
| Cash & Short-Term Investments | 532 M |
| Receivables | 42 M |
| Other Current Assets | 13.7 M |
| Non-Current Assets | 230 M |
| Long-Term Investments | 62 M |
| PP&E | 168 M |
| Other Non-Current Assets | 263 K |
| Current Liabilities | 33.1 M |
| Accounts Payable | 1.85 M |
| Short-Term Debt | 2.95 M |
| Other Current Liabilities | 28.3 M |
| Non-Current Liabilities | 6.62 M |
| Long-Term Debt | 6.62 M |
| Other Non-Current Liabilities | 0 |
EFFICIENCY
Earnings Waterfall
Krystal Biotech, Inc.
| Revenue | 50.7 M |
| Cost Of Revenue | 3.09 M |
| Gross Profit | 47.6 M |
| Operating Expenses | 160 M |
| Operating Income | -110 M |
| Other Expenses | -121 M |
| Net Income | 10.9 M |
RATIOS
93.90%
GROSS MARGIN
-216.43%
OPERATING MARGIN
21.56%
NET MARGIN
1.40%
ROE
1.34%
ROA
-11.92%
ROIC
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Krystal Biotech, Inc.
| Net Income | 10.9 M |
| Depreciation & Amortization | 5.01 M |
| Capital Expenditures | -11.8 M |
| Stock-Based Compensation | 39.9 M |
| Change in Working Capital | -37.9 M |
| Others | -98.1 M |
| Free Cash Flow | -101 M |
Wall Street Analysts Price Targets
Krystal Biotech, Inc.
Wall Street analysts predict an average 1-year price target for KRYS of $209 , with forecasts ranging from a low of $204 to a high of $220 .
KRYS Lowest Price Target
Wall Street Target
204 USD
19.48%
KRYS Average Price Target
Wall Street Target
209 USD
22.26%
KRYS Highest Price Target
Wall Street Target
220 USD
28.85%
4. DIVIDEND ANALYSIS
0.00%
DIVIDEND YIELD
0 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Krystal Biotech, Inc.
Sold
0-3 MONTHS
19.8 M USD 2
3-6 MONTHS
20.9 M USD 3
6-9 MONTHS
20.2 M USD 3
9-12 MONTHS
10.9 M USD 3
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|---|---|---|---|
|
2 months ago
Sep 12, 2024
|
Sell 772 K USD
|
Krishnan Suma
President, R&D |
- 3957
|
195.1627 USD |
|
2 months ago
Sep 12, 2024
|
Sell 1.26 M USD
|
Krishnan Suma
President, R&D |
- 6458
|
195.7226 USD |
|
2 months ago
Sep 12, 2024
|
Sell 334 K USD
|
Krishnan Suma
President, R&D |
- 1696
|
197.0387 USD |
|
2 months ago
Sep 12, 2024
|
Sell 413 K USD
|
Krishnan Suma
President, R&D |
- 2086
|
198.0803 USD |
|
2 months ago
Sep 12, 2024
|
Sell 797 K USD
|
Krishnan Suma
President, R&D |
- 4008
|
198.9264 USD |
|
2 months ago
Sep 12, 2024
|
Sell 721 K USD
|
Krishnan Suma
President, R&D |
- 3600
|
200.1522 USD |
|
2 months ago
Sep 12, 2024
|
Sell 481 K USD
|
Krishnan Suma
President, R&D |
- 2395
|
200.9758 USD |
|
2 months ago
Sep 12, 2024
|
Sell 161 K USD
|
Krishnan Suma
President, R&D |
- 800
|
201.8085 USD |
|
2 months ago
Sep 12, 2024
|
Sell 1.66 M USD
|
Krishnan Suma
President, R&D |
- 8497
|
195.4297 USD |
|
2 months ago
Sep 12, 2024
|
Sell 535 K USD
|
Krishnan Suma
President, R&D |
- 2727
|
196.0668 USD |
|
2 months ago
Sep 12, 2024
|
Sell 274 K USD
|
Krishnan Suma
President, R&D |
- 1385
|
197.5454 USD |
|
2 months ago
Sep 12, 2024
|
Sell 673 K USD
|
Krishnan Suma
President, R&D |
- 3392
|
198.433 USD |
|
2 months ago
Sep 12, 2024
|
Sell 587 K USD
|
Krishnan Suma
President, R&D |
- 2945
|
199.2231 USD |
|
2 months ago
Sep 12, 2024
|
Sell 834 K USD
|
Krishnan Suma
President, R&D |
- 4159
|
200.4149 USD |
|
2 months ago
Sep 12, 2024
|
Sell 382 K USD
|
Krishnan Suma
President, R&D |
- 1895
|
201.5177 USD |
|
2 months ago
Sep 12, 2024
|
Sell 772 K USD
|
Krishnan Krish S
President and CEO |
- 3957
|
195.1627 USD |
|
2 months ago
Sep 12, 2024
|
Sell 1.26 M USD
|
Krishnan Krish S
President and CEO |
- 6458
|
195.7226 USD |
|
2 months ago
Sep 12, 2024
|
Sell 334 K USD
|
Krishnan Krish S
President and CEO |
- 1696
|
197.0387 USD |
|
2 months ago
Sep 12, 2024
|
Sell 413 K USD
|
Krishnan Krish S
President and CEO |
- 2086
|
198.0803 USD |
|
2 months ago
Sep 12, 2024
|
Sell 797 K USD
|
Krishnan Krish S
President and CEO |
- 4008
|
198.9264 USD |
|
2 months ago
Sep 12, 2024
|
Sell 721 K USD
|
Krishnan Krish S
President and CEO |
- 3600
|
200.1522 USD |
|
2 months ago
Sep 12, 2024
|
Sell 481 K USD
|
Krishnan Krish S
President and CEO |
- 2395
|
200.9758 USD |
|
2 months ago
Sep 12, 2024
|
Sell 161 K USD
|
Krishnan Krish S
President and CEO |
- 800
|
201.8085 USD |
|
2 months ago
Sep 12, 2024
|
Sell 1.66 M USD
|
Krishnan Krish S
President and CEO |
- 8497
|
195.4297 USD |
|
2 months ago
Sep 12, 2024
|
Sell 535 K USD
|
Krishnan Krish S
President and CEO |
- 2727
|
196.0668 USD |
|
2 months ago
Sep 12, 2024
|
Sell 274 K USD
|
Krishnan Krish S
President and CEO |
- 1385
|
197.5454 USD |
|
2 months ago
Sep 12, 2024
|
Sell 673 K USD
|
Krishnan Krish S
President and CEO |
- 3392
|
198.433 USD |
|
2 months ago
Sep 12, 2024
|
Sell 587 K USD
|
Krishnan Krish S
President and CEO |
- 2945
|
199.2231 USD |
|
2 months ago
Sep 12, 2024
|
Sell 834 K USD
|
Krishnan Krish S
President and CEO |
- 4159
|
200.4149 USD |
|
2 months ago
Sep 12, 2024
|
Sell 382 K USD
|
Krishnan Krish S
President and CEO |
- 1895
|
201.5177 USD |
|
5 months ago
Jun 11, 2024
|
Sell 189 K USD
|
Krishnan Suma
President, R&D |
- 1100
|
171.488 USD |
|
5 months ago
Jun 11, 2024
|
Sell 324 K USD
|
Krishnan Suma
President, R&D |
- 1882
|
172.2128 USD |
|
5 months ago
Jun 11, 2024
|
Sell 229 K USD
|
Krishnan Suma
President, R&D |
- 1318
|
173.4875 USD |
|
5 months ago
Jun 11, 2024
|
Sell 699 K USD
|
Krishnan Suma
President, R&D |
- 4000
|
174.8261 USD |
|
5 months ago
Jun 11, 2024
|
Sell 800 K USD
|
Krishnan Suma
President, R&D |
- 4550
|
175.7568 USD |
|
5 months ago
Jun 11, 2024
|
Sell 1.01 M USD
|
Krishnan Suma
President, R&D |
- 5705
|
176.6786 USD |
|
5 months ago
Jun 11, 2024
|
Sell 968 K USD
|
Krishnan Suma
President, R&D |
- 5447
|
177.6784 USD |
|
5 months ago
Jun 11, 2024
|
Sell 178 K USD
|
Krishnan Suma
President, R&D |
- 998
|
178.3564 USD |
|
5 months ago
Jun 11, 2024
|
Sell 154 K USD
|
Krishnan Suma
President, R&D |
- 900
|
171.3962 USD |
|
5 months ago
Jun 11, 2024
|
Sell 362 K USD
|
Krishnan Suma
President, R&D |
- 2099
|
172.2385 USD |
|
5 months ago
Jun 11, 2024
|
Sell 209 K USD
|
Krishnan Suma
President, R&D |
- 1206
|
173.414 USD |
|
5 months ago
Jun 11, 2024
|
Sell 301 K USD
|
Krishnan Suma
President, R&D |
- 1724
|
174.4962 USD |
|
5 months ago
Jun 11, 2024
|
Sell 872 K USD
|
Krishnan Suma
President, R&D |
- 4975
|
175.3313 USD |
|
5 months ago
Jun 11, 2024
|
Sell 1.03 M USD
|
Krishnan Suma
President, R&D |
- 5867
|
176.375 USD |
|
5 months ago
Jun 11, 2024
|
Sell 1.13 M USD
|
Krishnan Suma
President, R&D |
- 6358
|
177.3785 USD |
|
5 months ago
Jun 11, 2024
|
Sell 333 K USD
|
Krishnan Suma
President, R&D |
- 1871
|
178.1447 USD |
|
5 months ago
Jun 11, 2024
|
Sell 189 K USD
|
Krishnan Krish S
President and CEO |
- 1100
|
171.488 USD |
|
5 months ago
Jun 11, 2024
|
Sell 324 K USD
|
Krishnan Krish S
President and CEO |
- 1882
|
172.2128 USD |
|
5 months ago
Jun 11, 2024
|
Sell 229 K USD
|
Krishnan Krish S
President and CEO |
- 1318
|
173.4875 USD |
|
5 months ago
Jun 11, 2024
|
Sell 699 K USD
|
Krishnan Krish S
President and CEO |
- 4000
|
174.8261 USD |
|
5 months ago
Jun 11, 2024
|
Sell 800 K USD
|
Krishnan Krish S
President and CEO |
- 4550
|
175.7568 USD |
|
5 months ago
Jun 11, 2024
|
Sell 1.01 M USD
|
Krishnan Krish S
President and CEO |
- 5705
|
176.6786 USD |
|
5 months ago
Jun 11, 2024
|
Sell 968 K USD
|
Krishnan Krish S
President and CEO |
- 5447
|
177.6784 USD |
|
5 months ago
Jun 11, 2024
|
Sell 178 K USD
|
Krishnan Krish S
President and CEO |
- 998
|
178.3564 USD |
|
5 months ago
Jun 11, 2024
|
Sell 154 K USD
|
Krishnan Krish S
President and CEO |
- 900
|
171.3962 USD |
|
5 months ago
Jun 11, 2024
|
Sell 362 K USD
|
Krishnan Krish S
President and CEO |
- 2099
|
172.2385 USD |
|
5 months ago
Jun 11, 2024
|
Sell 209 K USD
|
Krishnan Krish S
President and CEO |
- 1206
|
173.414 USD |
|
5 months ago
Jun 11, 2024
|
Sell 301 K USD
|
Krishnan Krish S
President and CEO |
- 1724
|
174.4962 USD |
|
5 months ago
Jun 11, 2024
|
Sell 872 K USD
|
Krishnan Krish S
President and CEO |
- 4975
|
175.3313 USD |
|
5 months ago
Jun 11, 2024
|
Sell 1.03 M USD
|
Krishnan Krish S
President and CEO |
- 5867
|
176.375 USD |
|
5 months ago
Jun 11, 2024
|
Sell 1.13 M USD
|
Krishnan Krish S
President and CEO |
- 6358
|
177.3785 USD |
|
5 months ago
Jun 11, 2024
|
Sell 333 K USD
|
Krishnan Krish S
President and CEO |
- 1871
|
178.1447 USD |
|
5 months ago
May 20, 2024
|
Sell 1.79 M USD
|
Gangolli Julian S
Director |
- 10930
|
163.7063 USD |
|
5 months ago
May 20, 2024
|
Sell 1.17 M USD
|
Gangolli Julian S
Director |
- 7090
|
164.3413 USD |
|
5 months ago
May 20, 2024
|
Sell 328 K USD
|
Gangolli Julian S
Director |
- 1980
|
165.7576 USD |
|
8 months ago
Mar 11, 2024
|
Sell 361 K USD
|
Krishnan Suma
President, R&D |
- 2146
|
167.9922 USD |
|
8 months ago
Mar 11, 2024
|
Sell 381 K USD
|
Krishnan Suma
President, R&D |
- 2254
|
168.8822 USD |
|
8 months ago
Mar 11, 2024
|
Sell 870 K USD
|
Krishnan Suma
President, R&D |
- 5109
|
170.3241 USD |
|
8 months ago
Mar 11, 2024
|
Sell 1.37 M USD
|
Krishnan Suma
President, R&D |
- 8002
|
170.9285 USD |
|
8 months ago
Mar 11, 2024
|
Sell 485 K USD
|
Krishnan Suma
President, R&D |
- 2816
|
172.0593 USD |
|
8 months ago
Mar 11, 2024
|
Sell 581 K USD
|
Krishnan Suma
President, R&D |
- 3359
|
173.0879 USD |
|
8 months ago
Mar 11, 2024
|
Sell 229 K USD
|
Krishnan Suma
President, R&D |
- 1314
|
173.9959 USD |
|
8 months ago
Mar 11, 2024
|
Sell 447 K USD
|
Krishnan Suma
President, R&D |
- 2658
|
168.1508 USD |
|
8 months ago
Mar 11, 2024
|
Sell 278 K USD
|
Krishnan Suma
President, R&D |
- 1646
|
168.9574 USD |
|
8 months ago
Mar 11, 2024
|
Sell 1.37 M USD
|
Krishnan Suma
President, R&D |
- 8040
|
170.4196 USD |
|
8 months ago
Mar 11, 2024
|
Sell 936 K USD
|
Krishnan Suma
President, R&D |
- 5469
|
171.0939 USD |
|
8 months ago
Mar 11, 2024
|
Sell 482 K USD
|
Krishnan Suma
President, R&D |
- 2800
|
172.2057 USD |
|
8 months ago
Mar 11, 2024
|
Sell 622 K USD
|
Krishnan Suma
President, R&D |
- 3587
|
173.2991 USD |
|
8 months ago
Mar 11, 2024
|
Sell 139 K USD
|
Krishnan Suma
President, R&D |
- 800
|
174.1313 USD |
|
8 months ago
Mar 11, 2024
|
Sell 361 K USD
|
Krishnan Krish S
President and CEO |
- 2146
|
167.9922 USD |
|
8 months ago
Mar 11, 2024
|
Sell 381 K USD
|
Krishnan Krish S
President and CEO |
- 2254
|
168.8822 USD |
|
8 months ago
Mar 11, 2024
|
Sell 870 K USD
|
Krishnan Krish S
President and CEO |
- 5109
|
170.3241 USD |
|
8 months ago
Mar 11, 2024
|
Sell 1.37 M USD
|
Krishnan Krish S
President and CEO |
- 8002
|
170.9285 USD |
|
8 months ago
Mar 11, 2024
|
Sell 485 K USD
|
Krishnan Krish S
President and CEO |
- 2816
|
172.0593 USD |
|
8 months ago
Mar 11, 2024
|
Sell 581 K USD
|
Krishnan Krish S
President and CEO |
- 3359
|
173.0879 USD |
|
8 months ago
Mar 11, 2024
|
Sell 229 K USD
|
Krishnan Krish S
President and CEO |
- 1314
|
173.9959 USD |
|
8 months ago
Mar 11, 2024
|
Sell 447 K USD
|
Krishnan Krish S
President and CEO |
- 2658
|
168.1508 USD |
|
8 months ago
Mar 11, 2024
|
Sell 278 K USD
|
Krishnan Krish S
President and CEO |
- 1646
|
168.9574 USD |
|
8 months ago
Mar 11, 2024
|
Sell 1.37 M USD
|
Krishnan Krish S
President and CEO |
- 8040
|
170.4196 USD |
|
8 months ago
Mar 11, 2024
|
Sell 936 K USD
|
Krishnan Krish S
President and CEO |
- 5469
|
171.0939 USD |
|
8 months ago
Mar 11, 2024
|
Sell 482 K USD
|
Krishnan Krish S
President and CEO |
- 2800
|
172.2057 USD |
|
8 months ago
Mar 11, 2024
|
Sell 622 K USD
|
Krishnan Krish S
President and CEO |
- 3587
|
173.2991 USD |
|
8 months ago
Mar 11, 2024
|
Sell 139 K USD
|
Krishnan Krish S
President and CEO |
- 800
|
174.1313 USD |
|
8 months ago
Feb 28, 2024
|
Sell 15.5 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 90
|
172.23 USD |
|
8 months ago
Feb 28, 2024
|
Sell 49.8 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 300
|
166.0633 USD |
|
8 months ago
Feb 28, 2024
|
Sell 236 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 1429
|
164.8075 USD |
|
8 months ago
Feb 28, 2024
|
Sell 147 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 900
|
163.6756 USD |
|
8 months ago
Feb 28, 2024
|
Sell 105 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 648
|
162.7102 USD |
|
8 months ago
Feb 28, 2024
|
Sell 19.9 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 117
|
169.8205 USD |
|
8 months ago
Feb 28, 2024
|
Sell 206 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 1216
|
169.0946 USD |
|
8 months ago
Feb 28, 2024
|
Sell 129 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 786
|
163.4937 USD |
|
8 months ago
Feb 28, 2024
|
Sell 104 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 637
|
162.7254 USD |
|
8 months ago
Feb 28, 2024
|
Sell 264 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 1600
|
164.8444 USD |
|
8 months ago
Feb 28, 2024
|
Sell 17.1 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 100
|
171.45 USD |
|
8 months ago
Feb 28, 2024
|
Sell 33.2 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 200
|
166.04 USD |
|
8 months ago
Feb 28, 2024
|
Sell 34.4 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 203
|
169.468 USD |
|
8 months ago
Feb 28, 2024
|
Sell 50.4 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 300
|
167.85 USD |
|
8 months ago
Feb 28, 2024
|
Sell 118 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 700
|
168.9136 USD |
|
8 months ago
Feb 28, 2024
|
Sell 192 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 1133
|
169.095 USD |
|
8 months ago
Feb 28, 2024
|
Sell 16.6 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 100
|
166.215 USD |
|
8 months ago
Feb 28, 2024
|
Sell 35.6 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 210
|
169.751 USD |
|
8 months ago
Feb 28, 2024
|
Sell 21.5 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 130
|
165.2197 USD |
|
8 months ago
Feb 28, 2024
|
Sell 23 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 134
|
171.6554 USD |
|
8 months ago
Feb 28, 2024
|
Sell 122 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 744
|
164.6031 USD |
|
8 months ago
Feb 28, 2024
|
Sell 85.3 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 523
|
163.134 USD |
|
8 months ago
Feb 26, 2024
|
Sell 675 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 5000
|
135 USD |
|
8 months ago
Feb 26, 2024
|
Sell 432 K USD
|
ROMANO KATHRYN
Chief Accounting Officer |
- 3087
|
140 USD |
|
9 months ago
Jan 22, 2024
|
Sell 325 K USD
|
Romano Kathryn
Chief Accounting Officer |
- 2500
|
130 USD |
|
11 months ago
Dec 11, 2023
|
Sell 459 K USD
|
Krishnan Suma
President, R&D |
- 4400
|
104.4146 USD |
|
11 months ago
Dec 11, 2023
|
Sell 661 K USD
|
Krishnan Suma
President, R&D |
- 6263
|
105.5039 USD |
|
11 months ago
Dec 11, 2023
|
Sell 1.51 M USD
|
Krishnan Suma
President, R&D |
- 14237
|
106.1085 USD |
|
11 months ago
Dec 11, 2023
|
Sell 10.8 K USD
|
Krishnan Suma
President, R&D |
- 100
|
107.66 USD |
|
11 months ago
Dec 11, 2023
|
Sell 298 K USD
|
Krishnan Suma
President, R&D |
- 2854
|
104.2639 USD |
|
11 months ago
Dec 11, 2023
|
Sell 477 K USD
|
Krishnan Suma
President, R&D |
- 4541
|
105.0621 USD |
|
11 months ago
Dec 11, 2023
|
Sell 1.86 M USD
|
Krishnan Suma
President, R&D |
- 17505
|
106.0406 USD |
|
11 months ago
Dec 11, 2023
|
Sell 10.8 K USD
|
Krishnan Suma
President, R&D |
- 100
|
107.66 USD |
|
11 months ago
Dec 11, 2023
|
Sell 459 K USD
|
Krishnan Krish S
President and CEO |
- 4400
|
104.4146 USD |
|
11 months ago
Dec 11, 2023
|
Sell 661 K USD
|
Krishnan Krish S
President and CEO |
- 6263
|
105.5039 USD |
|
11 months ago
Dec 11, 2023
|
Sell 1.51 M USD
|
Krishnan Krish S
President and CEO |
- 14237
|
106.1085 USD |
|
11 months ago
Dec 11, 2023
|
Sell 10.8 K USD
|
Krishnan Krish S
President and CEO |
- 100
|
107.66 USD |
|
11 months ago
Dec 11, 2023
|
Sell 298 K USD
|
Krishnan Krish S
President and CEO |
- 2854
|
104.2639 USD |
|
11 months ago
Dec 11, 2023
|
Sell 477 K USD
|
Krishnan Krish S
President and CEO |
- 4541
|
105.0621 USD |
|
11 months ago
Dec 11, 2023
|
Sell 1.86 M USD
|
Krishnan Krish S
President and CEO |
- 17505
|
106.0406 USD |
|
11 months ago
Dec 11, 2023
|
Sell 10.8 K USD
|
Krishnan Krish S
President and CEO |
- 100
|
107.66 USD |
|
1 year ago
Sep 11, 2023
|
Sell 627 K USD
|
Krishnan Suma
President, R&D |
- 5008
|
125.2275 USD |
|
1 year ago
Sep 11, 2023
|
Sell 688 K USD
|
Krishnan Suma
President, R&D |
- 5452
|
126.1677 USD |
|
1 year ago
Sep 11, 2023
|
Sell 238 K USD
|
Krishnan Suma
President, R&D |
- 1873
|
127.1832 USD |
|
1 year ago
Sep 11, 2023
|
Sell 1.36 M USD
|
Krishnan Suma
President, R&D |
- 10557
|
128.3713 USD |
|
1 year ago
Sep 11, 2023
|
Sell 272 K USD
|
Krishnan Suma
President, R&D |
- 2110
|
129.1013 USD |
|
1 year ago
Sep 11, 2023
|
Sell 627 K USD
|
Krishnan Suma
President, R&D |
- 5007
|
125.2275 USD |
|
1 year ago
Sep 11, 2023
|
Sell 688 K USD
|
Krishnan Suma
President, R&D |
- 5452
|
126.1676 USD |
|
1 year ago
Sep 11, 2023
|
Sell 238 K USD
|
Krishnan Suma
President, R&D |
- 1874
|
127.1833 USD |
|
1 year ago
Sep 11, 2023
|
Sell 1.36 M USD
|
Krishnan Suma
President, R&D |
- 10557
|
128.3713 USD |
|
1 year ago
Sep 11, 2023
|
Sell 272 K USD
|
Krishnan Suma
President, R&D |
- 2110
|
129.1014 USD |
|
1 year ago
Sep 11, 2023
|
Sell 627 K USD
|
Krishnan Krish S
President and CEO |
- 5008
|
125.2275 USD |
|
1 year ago
Sep 11, 2023
|
Sell 688 K USD
|
Krishnan Krish S
President and CEO |
- 5452
|
126.1677 USD |
|
1 year ago
Sep 11, 2023
|
Sell 238 K USD
|
Krishnan Krish S
President and CEO |
- 1873
|
127.1832 USD |
|
1 year ago
Sep 11, 2023
|
Sell 1.36 M USD
|
Krishnan Krish S
President and CEO |
- 10557
|
128.3713 USD |
|
1 year ago
Sep 11, 2023
|
Sell 272 K USD
|
Krishnan Krish S
President and CEO |
- 2110
|
129.1013 USD |
|
1 year ago
Sep 11, 2023
|
Sell 627 K USD
|
Krishnan Krish S
President and CEO |
- 5007
|
125.2275 USD |
|
1 year ago
Sep 11, 2023
|
Sell 688 K USD
|
Krishnan Krish S
President and CEO |
- 5452
|
126.1676 USD |
|
1 year ago
Sep 11, 2023
|
Sell 238 K USD
|
Krishnan Krish S
President and CEO |
- 1874
|
127.1833 USD |
|
1 year ago
Sep 11, 2023
|
Sell 1.36 M USD
|
Krishnan Krish S
President and CEO |
- 10557
|
128.3713 USD |
|
1 year ago
Sep 11, 2023
|
Sell 272 K USD
|
Krishnan Krish S
President and CEO |
- 2110
|
129.1014 USD |
|
1 year ago
Jun 08, 2023
|
Sell 589 K USD
|
JANNEY DANIEL
Director |
- 4604
|
127.9578 USD |
|
1 year ago
Jun 08, 2023
|
Sell 138 K USD
|
JANNEY DANIEL
Director |
- 1073
|
129.0218 USD |
|
1 year ago
Jun 08, 2023
|
Sell 694 K USD
|
JANNEY DANIEL
Director |
- 5388
|
128.7335 USD |
|
1 year ago
Jun 08, 2023
|
Sell 640 K USD
|
JANNEY DANIEL
Director |
- 5000
|
127.958 USD |
|
1 year ago
Jun 08, 2023
|
Sell 1.28 M USD
|
JANNEY DANIEL
Director |
- 10000
|
127.9584 USD |
|
1 year ago
Jun 08, 2023
|
Sell 639 K USD
|
JANNEY DANIEL
Director |
- 5000
|
127.8612 USD |
|
1 year ago
Jun 09, 2023
|
Sell 509 K USD
|
JANNEY DANIEL
Director |
- 3935
|
129.2943 USD |
|
1 year ago
Jun 09, 2023
|
Sell 644 K USD
|
JANNEY DANIEL
Director |
- 5000
|
128.8375 USD |
|
1 year ago
Jun 09, 2023
|
Sell 1.29 M USD
|
JANNEY DANIEL
Director |
- 10000
|
128.5262 USD |
|
1 year ago
Jun 09, 2023
|
Sell 674 K USD
|
ORTH ANDREW C.
Chief Commercial Officer |
- 5261
|
128.1045 USD |
|
1 year ago
Jun 09, 2023
|
Sell 890 K USD
|
ORTH ANDREW C.
Chief Commercial Officer |
- 6906
|
128.9441 USD |
|
1 year ago
Jun 09, 2023
|
Sell 43.2 K USD
|
ORTH ANDREW C.
Chief Commercial Officer |
- 333
|
129.6972 USD |
|
1 year ago
May 31, 2023
|
Sell 2.19 M USD
|
Krishnan Suma
President, R&D |
- 18884
|
115.995 USD |
|
1 year ago
May 31, 2023
|
Sell 668 K USD
|
Krishnan Suma
President, R&D |
- 5716
|
116.9498 USD |
|
1 year ago
May 31, 2023
|
Sell 47 K USD
|
Krishnan Suma
President, R&D |
- 400
|
117.605 USD |
|
1 year ago
May 31, 2023
|
Sell 2.34 M USD
|
Krishnan Suma
President, R&D |
- 20143
|
115.9757 USD |
|
1 year ago
May 31, 2023
|
Sell 533 K USD
|
Krishnan Suma
President, R&D |
- 4557
|
116.8624 USD |
|
1 year ago
May 31, 2023
|
Sell 35.3 K USD
|
Krishnan Suma
President, R&D |
- 300
|
117.5733 USD |
|
1 year ago
May 31, 2023
|
Sell 2.19 M USD
|
Krishnan Krish S
President and CEO |
- 18884
|
115.995 USD |
|
1 year ago
May 31, 2023
|
Sell 668 K USD
|
Krishnan Krish S
President and CEO |
- 5716
|
116.9498 USD |
|
1 year ago
May 31, 2023
|
Sell 47 K USD
|
Krishnan Krish S
President and CEO |
- 400
|
117.605 USD |
|
1 year ago
May 31, 2023
|
Sell 2.34 M USD
|
Krishnan Krish S
President and CEO |
- 20143
|
115.9757 USD |
|
1 year ago
May 31, 2023
|
Sell 533 K USD
|
Krishnan Krish S
President and CEO |
- 4557
|
116.8624 USD |
|
1 year ago
May 31, 2023
|
Sell 35.3 K USD
|
Krishnan Krish S
President and CEO |
- 300
|
117.5733 USD |
|
1 year ago
May 19, 2023
|
Sell 1.19 M USD
|
Romano Kathryn
Chief Accounting Officer |
- 12500
|
95.0449 USD |
|
1 year ago
May 19, 2023
|
Sell 1.19 M USD
|
Romano Kathryn
Chief Accounting Officer |
- 12500
|
95.05 USD |
|
1 year ago
May 22, 2023
|
Sell 1.38 M USD
|
Romano Kathryn
Chief Accounting Officer |
- 12500
|
110 USD |
|
1 year ago
May 19, 2023
|
Sell 326 K USD
|
Romano Kathryn
Chief Accounting Officer |
- 3428
|
95.0808 USD |
|
1 year ago
May 22, 2023
|
Sell 347 K USD
|
Romano Kathryn
Chief Accounting Officer |
- 3154
|
109.9933 USD |
|
1 year ago
May 22, 2023
|
Sell 140 K USD
|
Romano Kathryn
Chief Accounting Officer |
- 1300
|
107.8777 USD |
|
1 year ago
May 22, 2023
|
Sell 323 K USD
|
Romano Kathryn
Chief Accounting Officer |
- 2955
|
109.1719 USD |
|
1 year ago
May 22, 2023
|
Sell 274 K USD
|
Romano Kathryn
Chief Accounting Officer |
- 2570
|
106.8087 USD |
|
1 year ago
May 22, 2023
|
Sell 267 K USD
|
Romano Kathryn
Chief Accounting Officer |
- 2521
|
105.8036 USD |
|
1 year ago
May 19, 2023
|
Sell 4.75 M USD
|
JANNEY DANIEL
Director |
- 50000
|
95.0237 USD |
|
1 year ago
May 09, 2023
|
Sell 1.55 M USD
|
JANNEY DANIEL
Director |
- 17100
|
90.7356 USD |
|
1 year ago
Apr 19, 2023
|
Sell 713 K USD
|
JANNEY DANIEL
Director |
- 7900
|
90.3156 USD |
|
1 year ago
Apr 17, 2023
|
Sell 89.8 K USD
|
Krishnan Suma
President, R&D |
- 1050
|
85.5483 USD |
|
1 year ago
Apr 17, 2023
|
Sell 373 K USD
|
Krishnan Suma
President, R&D |
- 4298
|
86.7964 USD |
|
1 year ago
Apr 17, 2023
|
Sell 824 K USD
|
Krishnan Suma
President, R&D |
- 9428
|
87.4113 USD |
|
1 year ago
Apr 17, 2023
|
Sell 860 K USD
|
Krishnan Suma
President, R&D |
- 9724
|
88.4062 USD |
|
1 year ago
Apr 17, 2023
|
Sell 44.6 K USD
|
Krishnan Suma
President, R&D |
- 500
|
89.1175 USD |
|
1 year ago
Apr 17, 2023
|
Sell 89.8 K USD
|
Krishnan Suma
President, R&D |
- 1050
|
85.5487 USD |
|
1 year ago
Apr 17, 2023
|
Sell 373 K USD
|
Krishnan Suma
President, R&D |
- 4297
|
86.7964 USD |
|
1 year ago
Apr 17, 2023
|
Sell 824 K USD
|
Krishnan Suma
President, R&D |
- 9429
|
87.4114 USD |
|
1 year ago
Apr 17, 2023
|
Sell 860 K USD
|
Krishnan Suma
President, R&D |
- 9724
|
88.4062 USD |
|
1 year ago
Apr 17, 2023
|
Sell 44.6 K USD
|
Krishnan Suma
President, R&D |
- 500
|
89.1175 USD |
|
1 year ago
Apr 17, 2023
|
Sell 89.8 K USD
|
Krishnan Krish S
President and CEO |
- 1050
|
85.5483 USD |
|
1 year ago
Apr 17, 2023
|
Sell 373 K USD
|
Krishnan Krish S
President and CEO |
- 4298
|
86.7964 USD |
|
1 year ago
Apr 17, 2023
|
Sell 824 K USD
|
Krishnan Krish S
President and CEO |
- 9428
|
87.4113 USD |
|
1 year ago
Apr 17, 2023
|
Sell 860 K USD
|
Krishnan Krish S
President and CEO |
- 9724
|
88.4062 USD |
|
1 year ago
Apr 17, 2023
|
Sell 44.6 K USD
|
Krishnan Krish S
President and CEO |
- 500
|
89.1175 USD |
|
1 year ago
Apr 17, 2023
|
Sell 89.8 K USD
|
Krishnan Krish S
President and CEO |
- 1050
|
85.5487 USD |
|
1 year ago
Apr 17, 2023
|
Sell 373 K USD
|
Krishnan Krish S
President and CEO |
- 4297
|
86.7964 USD |
|
1 year ago
Apr 17, 2023
|
Sell 824 K USD
|
Krishnan Krish S
President and CEO |
- 9429
|
87.4114 USD |
|
1 year ago
Apr 17, 2023
|
Sell 860 K USD
|
Krishnan Krish S
President and CEO |
- 9724
|
88.4062 USD |
|
1 year ago
Apr 17, 2023
|
Sell 44.6 K USD
|
Krishnan Krish S
President and CEO |
- 500
|
89.1175 USD |
|
1 year ago
Mar 01, 2023
|
Sell 3.33 M USD
|
ROSSI DINO A
Director |
- 40000
|
83.2493 USD |
|
1 year ago
Jan 17, 2023
|
Sell 1.66 M USD
|
Krishnan Suma
President, R&D |
- 20617
|
80.7019 USD |
|
1 year ago
Jan 17, 2023
|
Sell 96.5 K USD
|
Krishnan Suma
President, R&D |
- 1186
|
81.4062 USD |
|
1 year ago
Jan 17, 2023
|
Sell 28.6 K USD
|
Krishnan Suma
President, R&D |
- 346
|
82.7144 USD |
|
1 year ago
Jan 18, 2023
|
Sell 165 K USD
|
Krishnan Suma
President, R&D |
- 2048
|
80.7531 USD |
|
1 year ago
Jan 18, 2023
|
Sell 65.5 K USD
|
Krishnan Suma
President, R&D |
- 803
|
81.5592 USD |
|
1 year ago
Jan 17, 2023
|
Sell 1.66 M USD
|
Krishnan Suma
President, R&D |
- 20617
|
80.7019 USD |
|
1 year ago
Jan 17, 2023
|
Sell 96.5 K USD
|
Krishnan Suma
President, R&D |
- 1186
|
81.4067 USD |
|
1 year ago
Jan 17, 2023
|
Sell 28.5 K USD
|
Krishnan Suma
President, R&D |
- 345
|
82.7153 USD |
|
1 year ago
Jan 18, 2023
|
Sell 165 K USD
|
Krishnan Suma
President, R&D |
- 2048
|
80.7527 USD |
|
1 year ago
Jan 18, 2023
|
Sell 65.6 K USD
|
Krishnan Suma
President, R&D |
- 804
|
81.5592 USD |
|
1 year ago
Jan 17, 2023
|
Sell 1.66 M USD
|
Krishnan Krish S
President and CEO |
- 20617
|
80.7019 USD |
|
1 year ago
Jan 17, 2023
|
Sell 96.5 K USD
|
Krishnan Krish S
President and CEO |
- 1186
|
81.4062 USD |
|
1 year ago
Jan 17, 2023
|
Sell 28.6 K USD
|
Krishnan Krish S
President and CEO |
- 346
|
82.7144 USD |
|
1 year ago
Jan 18, 2023
|
Sell 165 K USD
|
Krishnan Krish S
President and CEO |
- 2048
|
80.7531 USD |
|
1 year ago
Jan 18, 2023
|
Sell 65.5 K USD
|
Krishnan Krish S
President and CEO |
- 803
|
81.5592 USD |
|
1 year ago
Jan 17, 2023
|
Sell 1.66 M USD
|
Krishnan Krish S
President and CEO |
- 20617
|
80.7019 USD |
|
1 year ago
Jan 17, 2023
|
Sell 96.5 K USD
|
Krishnan Krish S
President and CEO |
- 1186
|
81.4067 USD |
|
1 year ago
Jan 17, 2023
|
Sell 28.5 K USD
|
Krishnan Krish S
President and CEO |
- 345
|
82.7153 USD |
|
1 year ago
Jan 18, 2023
|
Sell 165 K USD
|
Krishnan Krish S
President and CEO |
- 2048
|
80.7527 USD |
|
1 year ago
Jan 18, 2023
|
Sell 65.6 K USD
|
Krishnan Krish S
President and CEO |
- 804
|
81.5592 USD |
|
1 year ago
Jan 04, 2023
|
Sell 300 K USD
|
Krishnan Suma
President, R&D |
- 3748
|
80.0801 USD |
|
1 year ago
Jan 04, 2023
|
Sell 315 K USD
|
Krishnan Suma
President, R&D |
- 3938
|
80.0876 USD |
|
1 year ago
Jan 04, 2023
|
Sell 300 K USD
|
Krishnan Krish S
President and CEO |
- 3748
|
80.0801 USD |
|
1 year ago
Jan 04, 2023
|
Sell 315 K USD
|
Krishnan Krish S
President and CEO |
- 3938
|
80.0876 USD |
|
1 year ago
Dec 29, 2022
|
Sell 598 K USD
|
Krishnan Suma
President, R&D |
- 7447
|
80.2805 USD |
|
1 year ago
Dec 29, 2022
|
Sell 45.7 K USD
|
Krishnan Suma
President, R&D |
- 563
|
81.1055 USD |
|
1 year ago
Jan 03, 2023
|
Sell 137 K USD
|
Krishnan Suma
President, R&D |
- 1700
|
80.3335 USD |
|
1 year ago
Dec 29, 2022
|
Sell 601 K USD
|
Krishnan Suma
President, R&D |
- 7484
|
80.2989 USD |
|
1 year ago
Dec 29, 2022
|
Sell 42.8 K USD
|
Krishnan Suma
President, R&D |
- 528
|
81.102 USD |
|
1 year ago
Jan 03, 2023
|
Sell 137 K USD
|
Krishnan Suma
President, R&D |
- 1700
|
80.326 USD |
|
1 year ago
Dec 29, 2022
|
Sell 598 K USD
|
Krishnan Krish S
President and CEO |
- 7447
|
80.2805 USD |
|
1 year ago
Dec 29, 2022
|
Sell 45.7 K USD
|
Krishnan Krish S
President and CEO |
- 563
|
81.1055 USD |
|
1 year ago
Jan 03, 2023
|
Sell 137 K USD
|
Krishnan Krish S
President and CEO |
- 1700
|
80.3335 USD |
|
1 year ago
Dec 29, 2022
|
Sell 601 K USD
|
Krishnan Krish S
President and CEO |
- 7484
|
80.2989 USD |
|
1 year ago
Dec 29, 2022
|
Sell 42.8 K USD
|
Krishnan Krish S
President and CEO |
- 528
|
81.102 USD |
|
1 year ago
Jan 03, 2023
|
Sell 137 K USD
|
Krishnan Krish S
President and CEO |
- 1700
|
80.326 USD |
|
1 year ago
Dec 16, 2022
|
Sell 847 K USD
|
Krishnan Suma
President, R&D |
- 10572
|
80.0999 USD |
|
1 year ago
Dec 16, 2022
|
Sell 843 K USD
|
Krishnan Suma
President, R&D |
- 10527
|
80.0959 USD |
|
1 year ago
Dec 16, 2022
|
Sell 847 K USD
|
Krishnan Krish S
President and CEO |
- 10572
|
80.0999 USD |
|
1 year ago
Dec 16, 2022
|
Sell 843 K USD
|
Krishnan Krish S
President and CEO |
- 10527
|
80.0959 USD |
|
1 year ago
Nov 23, 2022
|
Sell 320 USD
|
Krishnan Suma
President, R&D |
- 4
|
80.01 USD |
|
1 year ago
Nov 23, 2022
|
Sell 320 USD
|
Krishnan Krish S
President and CEO |
- 4
|
80.01 USD |
|
2 years ago
Nov 08, 2022
|
Sell 77.3 K USD
|
Krishnan Suma
President, R&D |
- 966
|
80.0523 USD |
|
2 years ago
Nov 08, 2022
|
Sell 65.9 K USD
|
Krishnan Suma
President, R&D |
- 823
|
80.0373 USD |
|
2 years ago
Nov 08, 2022
|
Sell 77.3 K USD
|
Krishnan Krish S
President and CEO |
- 966
|
80.0523 USD |
|
2 years ago
Nov 08, 2022
|
Sell 65.9 K USD
|
Krishnan Krish S
President and CEO |
- 823
|
80.0373 USD |
|
2 years ago
Aug 05, 2022
|
Sell 729 K USD
|
Krishnan Suma
President, R&D |
- 9088
|
80.2386 USD |
|
2 years ago
Aug 05, 2022
|
Sell 721 K USD
|
Krishnan Krish S
President and CEO |
- 8992
|
80.2193 USD |
|
2 years ago
Dec 10, 2021
|
Sell 7.05 M USD
|
Krishnan Suma
Chief Operating Officer |
- 100000
|
70.5 USD |
|
2 years ago
Dec 10, 2021
|
Sell 7.05 M USD
|
JANNEY DANIEL
Director |
- 100000
|
70.5 USD |
|
2 years ago
Dec 10, 2021
|
Sell 7.05 M USD
|
Krishnan Krish S
President and CEO |
- 100000
|
70.5 USD |
|
4 years ago
Sep 15, 2020
|
Sell 667 K USD
|
Krishnan Suma
Chief Operating Officer |
- 14435
|
46.2093 USD |
|
4 years ago
Sep 15, 2020
|
Sell 71.5 K USD
|
Krishnan Suma
Chief Operating Officer |
- 1517
|
47.1478 USD |
|
4 years ago
Sep 16, 2020
|
Sell 451 K USD
|
Krishnan Suma
Chief Operating Officer |
- 9749
|
46.2428 USD |
|
4 years ago
Sep 16, 2020
|
Sell 241 K USD
|
Krishnan Suma
Chief Operating Officer |
- 5142
|
46.8486 USD |
|
4 years ago
Sep 17, 2020
|
Sell 488 K USD
|
Krishnan Suma
Chief Operating Officer |
- 10594
|
46.0918 USD |
|
4 years ago
Sep 17, 2020
|
Sell 347 K USD
|
Krishnan Suma
Chief Operating Officer |
- 7437
|
46.6335 USD |
|
4 years ago
Sep 17, 2020
|
Sell 53.2 K USD
|
Krishnan Suma
Chief Operating Officer |
- 1126
|
47.2898 USD |
|
4 years ago
Jun 15, 2020
|
Sell 313 K USD
|
Krishnan Suma
Chief Operating Officer |
- 7578
|
41.3088 USD |
|
4 years ago
Jun 15, 2020
|
Sell 365 K USD
|
Krishnan Suma
Chief Operating Officer |
- 8652
|
42.2361 USD |
|
4 years ago
Jun 15, 2020
|
Sell 464 K USD
|
Krishnan Suma
Chief Operating Officer |
- 10740
|
43.2095 USD |
|
4 years ago
Jun 15, 2020
|
Sell 504 K USD
|
Krishnan Suma
Chief Operating Officer |
- 11311
|
44.5635 USD |
|
4 years ago
Jun 15, 2020
|
Sell 528 K USD
|
Krishnan Suma
Chief Operating Officer |
- 11719
|
45.0706 USD |
|
4 years ago
May 15, 2020
|
Sell 221 K USD
|
Krishnan Krish S
President and CEO |
- 3842
|
57.4282 USD |
|
4 years ago
May 15, 2020
|
Sell 723 K USD
|
Krishnan Krish S
President and CEO |
- 12445
|
58.0854 USD |
|
4 years ago
May 15, 2020
|
Sell 623 K USD
|
Krishnan Krish S
President and CEO |
- 10552
|
59.029 USD |
|
4 years ago
May 18, 2020
|
Sell 162 K USD
|
Krishnan Krish S
President and CEO |
- 2900
|
55.985 USD |
|
4 years ago
May 18, 2020
|
Sell 386 K USD
|
Krishnan Krish S
President and CEO |
- 6784
|
56.838 USD |
|
4 years ago
May 18, 2020
|
Sell 310 K USD
|
Krishnan Krish S
President and CEO |
- 5371
|
57.6302 USD |
|
4 years ago
May 18, 2020
|
Sell 107 K USD
|
Krishnan Krish S
President and CEO |
- 1805
|
59.113 USD |
|
4 years ago
May 18, 2020
|
Sell 376 K USD
|
Krishnan Krish S
President and CEO |
- 6301
|
59.7278 USD |
|
4 years ago
Mar 16, 2020
|
Sell 103 K USD
|
Krishnan Suma
Chief Operating Officer |
- 2559
|
40.1384 USD |
|
4 years ago
Mar 17, 2020
|
Sell 436 K USD
|
Krishnan Suma
Chief Operating Officer |
- 10780
|
40.4851 USD |
|
4 years ago
Mar 17, 2020
|
Sell 57.6 K USD
|
Krishnan Suma
Chief Operating Officer |
- 1396
|
41.2658 USD |
|
4 years ago
Mar 17, 2020
|
Sell 168 USD
|
Krishnan Suma
Chief Operating Officer |
- 4
|
42.03 USD |
|
4 years ago
Mar 18, 2020
|
Sell 26.5 K USD
|
Krishnan Suma
Chief Operating Officer |
- 659
|
40.2018 USD |
|
4 years ago
Feb 18, 2020
|
Sell 466 K USD
|
Krishnan Krish S
President and CEO |
- 7481
|
62.2594 USD |
|
4 years ago
Feb 18, 2020
|
Sell 289 K USD
|
Krishnan Krish S
President and CEO |
- 4588
|
62.9754 USD |
|
4 years ago
Feb 18, 2020
|
Sell 38.4 K USD
|
Krishnan Krish S
President and CEO |
- 600
|
63.9533 USD |
|
4 years ago
Feb 19, 2020
|
Sell 1.01 M USD
|
Krishnan Krish S
President and CEO |
- 16033
|
62.6962 USD |
|
4 years ago
Feb 19, 2020
|
Sell 165 K USD
|
Krishnan Krish S
President and CEO |
- 2617
|
63.1466 USD |
|
4 years ago
Feb 20, 2020
|
Sell 131 K USD
|
Krishnan Krish S
President and CEO |
- 2192
|
59.596 USD |
|
4 years ago
Feb 20, 2020
|
Sell 608 K USD
|
Krishnan Krish S
President and CEO |
- 10022
|
60.7054 USD |
|
4 years ago
Feb 20, 2020
|
Sell 219 K USD
|
Krishnan Krish S
President and CEO |
- 3561
|
61.5209 USD |
|
4 years ago
Feb 20, 2020
|
Sell 181 K USD
|
Krishnan Krish S
President and CEO |
- 2906
|
62.3769 USD |
|
4 years ago
Dec 16, 2019
|
Sell 463 K USD
|
Krishnan Suma
Chief Operating Officer |
- 7373
|
62.8444 USD |
|
4 years ago
Dec 16, 2019
|
Sell 471 K USD
|
Krishnan Suma
Chief Operating Officer |
- 7396
|
63.6235 USD |
|
4 years ago
Dec 16, 2019
|
Sell 376 K USD
|
Krishnan Suma
Chief Operating Officer |
- 5856
|
64.2782 USD |
|
4 years ago
Dec 16, 2019
|
Sell 21.1 K USD
|
Krishnan Suma
Chief Operating Officer |
- 322
|
65.6042 USD |
|
4 years ago
Dec 17, 2019
|
Sell 487 K USD
|
Krishnan Suma
Chief Operating Officer |
- 8138
|
59.8676 USD |
|
4 years ago
Dec 17, 2019
|
Sell 532 K USD
|
Krishnan Suma
Chief Operating Officer |
- 8799
|
60.461 USD |
|
4 years ago
Dec 17, 2019
|
Sell 55 K USD
|
Krishnan Suma
Chief Operating Officer |
- 891
|
61.7222 USD |
|
4 years ago
Dec 17, 2019
|
Sell 115 K USD
|
Krishnan Suma
Chief Operating Officer |
- 1834
|
62.7907 USD |
|
4 years ago
Dec 17, 2019
|
Sell 17.7 K USD
|
Krishnan Suma
Chief Operating Officer |
- 279
|
63.3472 USD |
|
4 years ago
Dec 18, 2019
|
Sell 71.4 K USD
|
Krishnan Suma
Chief Operating Officer |
- 1200
|
59.4893 USD |
|
4 years ago
Dec 18, 2019
|
Sell 61.2 K USD
|
Krishnan Suma
Chief Operating Officer |
- 1017
|
60.1921 USD |
|
4 years ago
Dec 18, 2019
|
Sell 55.2 K USD
|
Krishnan Suma
Chief Operating Officer |
- 900
|
61.2811 USD |
|
4 years ago
Dec 18, 2019
|
Sell 361 K USD
|
Krishnan Suma
Chief Operating Officer |
- 5756
|
62.6463 USD |
|
4 years ago
Dec 18, 2019
|
Sell 15.1 K USD
|
Krishnan Suma
Chief Operating Officer |
- 239
|
63.3143 USD |
|
5 years ago
Nov 15, 2019
|
Sell 591 K USD
|
Krishnan Krish S
President and CEO |
- 11895
|
49.7242 USD |
|
5 years ago
Nov 15, 2019
|
Sell 577 K USD
|
Krishnan Krish S
President and CEO |
- 11386
|
50.6903 USD |
|
5 years ago
Nov 15, 2019
|
Sell 237 K USD
|
Krishnan Krish S
President and CEO |
- 4598
|
51.4696 USD |
|
5 years ago
Nov 18, 2019
|
Sell 53.3 K USD
|
Krishnan Krish S
President and CEO |
- 1046
|
50.9768 USD |
|
5 years ago
Nov 18, 2019
|
Sell 545 K USD
|
Krishnan Krish S
President and CEO |
- 10513
|
51.8162 USD |
|
5 years ago
Nov 18, 2019
|
Sell 426 K USD
|
Krishnan Krish S
President and CEO |
- 8080
|
52.6787 USD |
|
5 years ago
Nov 18, 2019
|
Sell 112 K USD
|
Krishnan Krish S
President and CEO |
- 2082
|
53.8618 USD |
|
5 years ago
Nov 18, 2019
|
Sell 21.8 K USD
|
Krishnan Krish S
President and CEO |
- 400
|
54.38 USD |
|
5 years ago
Aug 29, 2019
|
Sell 2.6 M USD
|
JANNEY DANIEL
Director |
- 55794
|
46.61 USD |
|
5 years ago
Aug 29, 2019
|
Sell 33.2 K USD
|
JANNEY DANIEL
Director |
- 700
|
47.5 USD |
|
5 years ago
Aug 30, 2019
|
Sell 1.49 M USD
|
JANNEY DANIEL
Director |
- 32190
|
46.18 USD |
|
6 years ago
Oct 18, 2018
|
Bought 500 K USD
|
Krishnan Suma
Chief Operating Officer |
+ 25000
|
20 USD |
|
6 years ago
Oct 18, 2018
|
Bought 500 K USD
|
Krishnan Krish S
President and CEO |
+ 25000
|
20 USD |
|
6 years ago
Jun 06, 2018
|
Bought 12.7 K USD
|
Krishnan Suma
Chief Operating Officer |
+ 1018
|
12.45 USD |
|
6 years ago
Jun 06, 2018
|
Bought 146 K USD
|
Krishnan Suma
Chief Operating Officer |
+ 13116
|
11.145 USD |
|
6 years ago
Jun 05, 2018
|
Bought 117 K USD
|
Krishnan Suma
Chief Operating Officer |
+ 10866
|
10.7452 USD |
|
6 years ago
May 22, 2018
|
Bought 30.1 K USD
|
Riley Antony A
Chief Financial Officer |
+ 2800
|
10.75 USD |
|
6 years ago
May 09, 2018
|
Bought 93.8 K USD
|
NORBY R DOUGLAS
Director |
+ 9000
|
10.42 USD |
|
6 years ago
Mar 19, 2018
|
Bought 550 K USD
|
Krishnan Krish S
President and CEO |
+ 50000
|
11 USD |
|
7 years ago
Sep 22, 2017
|
Bought 2 M USD
|
JANNEY DANIEL
Director |
+ 200000
|
10 USD |
|
7 years ago
Sep 22, 2017
|
Bought 1 M USD
|
Krishnan Suma
Chief Operating Officer |
+ 100000
|
10 USD |
|
7 years ago
Sep 22, 2017
|
Bought 1 M USD
|
Krishnan Krish S
President and CEO |
+ 100000
|
10 USD |
7. News
Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference
PITTSBURGH, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc . (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the Guggenheim Securities Healthcare Innovation Conference on November 12, 2024, in Boston. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 1:30 pm ET and host investor meetings throughout the day.
globenewswire.com
- 1 week ago
Krystal Q3 Earnings and Sales Top Estimates, Vyjuvek Gains Traction
KRYS beat on both earnings and sales in the third quarter of 2024. Lead drug Vyjuvek's launch in the United States shows strong uptake.
zacks.com
- 1 week ago
Krystal Biotech, Inc. (KRYS) Q3 2024 Earnings Call Transcript
Krystal Biotech, Inc. (NASDAQ:KRYS ) Q3 2024 Earnings Conference Call November 4, 2024 8:30 AM ET Company Participants Stéphane Paquette - VP, Corporate Development Krish Krishnan - Chairman and CEO Suma Krishnan - President, Research and Development Jennifer McDonough - SVP, Patient Access, Analytics and Operations Christine Wilson - SVP and Head, U.S. Sales and Marketing Kate Romano - CAO Conference Call Participants Alec Stranahan - BOA Yigal Nochomovitz - Citigroup Ritu Baral - TD Cowen Sami Corwin - William Blair Gavin Clark-Gartner - Evercore ISI Dae Gon Ha - Stifel Debjit Chattopadhyay - Guggenheim Securities Andrea Newkirk - Goldman Sachs Operator Thank you for standing by and welcome to Krystal Biotech's Third Quarter Earnings Conference Call. [Operator Instructions] As a reminder, today's conference is being recorded.
seekingalpha.com
- 1 week ago
Krystal Biotech, Inc. (KRYS) Beats Q3 Earnings and Revenue Estimates
Krystal Biotech, Inc. (KRYS) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to loss of $0.67 per share a year ago.
zacks.com
- 1 week ago
Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth
Krystal Biotech (KRYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zacks.com
- 2 weeks ago
Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024
PITTSBURGH, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its third quarter 2024 financial results on Monday, November 4, 2024, prior to the open of U.S. markets.
globenewswire.com
- 2 weeks ago
All You Need to Know About Krystal Biotech (KRYS) Rating Upgrade to Buy
Krystal Biotech (KRYS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
zacks.com
- 4 weeks ago
Krystal Biotech: Q4 Catalysts Expected With VYJUVEK Revenue Growth Pressing On
The company anticipates significant Q4 2024 data releases for KB707 in solid tumors and KB408 in AATD lung disease, potentially boosting shareholder value. Jeune Therapeutics, a subsidiary, shows promise in aesthetics with positive phase 1 data, changing the treatment paradigm in the aesthetics market space. VYJUVEK, approved for DEB, saw a 55.3% revenue increase in Q2 2024, with potential European expansion pending MAA approval.
seekingalpha.com
- 1 month ago
Krystal Biotech to Present at 2024 Cantor Global Healthcare Conference
PITTSBURGH, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc . (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the 2024 Cantor Global Healthcare Conference on September 18, 2024, in New York. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 1:20 pm ET and host investor meetings throughout the day.
globenewswire.com
- 2 months ago
Krystal Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference
PITTSBURGH, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc . (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the H.C. Wainwright 26th Annual Global Investment Conference on September 10, 2024, in New York. Krish S. Krishnan, Chairman and Chief Executive Officer, is scheduled to give a company presentation at 12:30 pm ET and host investor meetings throughout the day.
globenewswire.com
- 2 months ago
Surging Earnings Estimates Signal Upside for Krystal Biotech (KRYS) Stock
Krystal Biotech (KRYS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
zacks.com
- 2 months ago
Krystal Biotech Stock Surges 21.9% in 3 Months: More Room to Grow?
KRYS has gained 21.9% in the past three months on strong uptake of its newly approved drug Vyjuvek and encouraging pipeline progress.
zacks.com
- 2 months ago
8. Profile Summary
Krystal Biotech, Inc. KRYS
COUNTRY
US
INDUSTRY
Biotechnology
MARKET CAP
$ 4.91 B
Dividend Yield
0.00%
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome. Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx product. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.
Contact
2100 Wharton Street, Pittsburgh, PA, 15203
https://www.krystalbio.com
IPO Date
Sept. 20, 2017
Employees
229
Officers
Mr. David Chien
Senior Vice President of Clinical Development
Ms. Jennifer McDonough
Senior Vice President of Patient Access, Analytics & Operations
Mr. John Thomas
General Counsel & Corporate Secretary
Mr. John Karakkal
Vice President of North American Sales & Marketing
Mr. Laurent Goux
Senior Vice President & GM of Europe
Ms. Suma M. Krishnan
Founder, President of R&D and Director
Mr. Krish S. Krishnan M.B.A., M.S.
Founder, Chairman, President & Chief Executive Officer
Ms. Christine Wilson
Head of U.S. Sales & Marketing
Dr. Stephane Paquette Ph.D.
Vice President of Corporate Development
Mr. Josh Suskin
Director of Human Resources & Operations